Copyright
©The Author(s) 2023.
World J Gastrointest Pharmacol Ther. May 5, 2023; 14(3): 22-32
Published online May 5, 2023. doi: 10.4292/wjgpt.v14.i3.22
Published online May 5, 2023. doi: 10.4292/wjgpt.v14.i3.22
Scorea | |||||
Organ system | 0 | 1 | 2 | 3 | 4 |
Respiration (PaO2/FiO2)b | > 400 | 301-400 | 201-300 | 101-200 | < 101 |
Kidney (serum creatinine), µmol/L | < 134 | 134-169 | 170-310 | 311-439 | > 439 |
Kidney (serum creatinine), mg/dL | < 1.4 | 1.4-1.8 | 1.9-3.6 | 3.7-4.9 | > 4.9 |
Cardiovascular (systolic blood pressure), mmHg | > 90 | < 90, fluid responsive | < 90, not fluid responsive | < 90, pH < 7.3 | < 90, pH < 7.2 |
Ref. | Design | N | Participants | Randomization | Aggressive resuscitation | Volume | Nonaggressive resuscitation | Volume | Effect of early aggressive resuscitation |
Mao et al[44], 2009 | Superiority | 76 | Severe AP | 72 h | Rapid volume expansion (10-15 ml/kg/h) | 4 ± 2 L Crystalloid; 1.3 ± 0.8 L; Colloid in 24 h | Controlled volume expansion (5-10 ml/kg/h) | 2.4 ± 1.9 L Crystalloid; 0.9 ± 0.6 L; Colloid in 24 h | Harmful, more sepsis, mortality, mechanical ventilation, and ACS |
Mao et al[46], 2010 | Superiority | 115 | Severe AP | 24 h | Rapid hemodilution with goal Hct < 35% at 48 h | - | Slow hemodilution with goal Hct > 35% at 48 h | - | Harmful, more sepsis, and mortality |
Wu et al[31], 2011 | Factorial | 40 | Any severity | 6 h | Goal-directed with 20 ml/kg bolus + 3 or 1.5 ml/kg/h of LR or NS | 4.3 L in 24h | LR or NS fluid therapy adjusted by treating physician | 4.6 L in 24h | Similar, SIRS, and CRP at 24 h |
Buxbaum et al[22], 2017 | Superiority | 60 | Predicted mild AP | 4 h | 20 ml/kg bolus + 3 ml/kg/h of LR | 5.6 L in 24 h; 7.6 L in 36 h | 10 ml/kg bolus then 1.5 ml/kg/h of LR | 3.9 L in 24 h; 5.6 L in 36 h | Beneficial, less composite outcome, SIRS, and hemoconcentration |
Cuéllar-Monterrubio JE et al[45], 2020 | Two-tailed | 88 | Any severity AP, more than 24 hr disease onset | 4 h | 20 mL/kg bolus + 3 mL/kg/hr first 24 hours and then 30 mL/kg for the next 24 hours | 8.54 ± 1.83 L in 48 h | 20 ml/kg bolus (if hypovolemia, 3/45) - 1.5 ml/kg/h of HS first 24 hours and then 30 mL/kg for the next 24 hours | 5.13 ± 1.28 L in 48 h | No benefit, no differences found in SIRS, pancreatic necrosis, Respiratory complication, AKI, and LOS |
De-Madaria E et al[47], 2022 | Two-tailed | 249 | Mild AP, less than 24 h disease onset | 8 h | 20 ml/kg bolus + 3 ml/kg/h of LR | 7.8 (6.5-9.8) L in 48h | 10 mL/kg bolus (if hypovolumia) - 1.5 ml/kg/h of LR | 5.5 (4.0-6.8) L in 48 h | Harmful, more fluid overload |
Parameter | Recommendation |
Who | All patients with any severity |
Timing | Early fluid resuscitation is better |
Type of fluid | Ringer lactate solutions better than normal saline solutions |
Avoid synthetic colloids (HES or Dextran), Limited data in human albumin | |
Amount of fluid | |
Mild pancreatitis | 3 L in 24 h and 4-6 L in 48 h |
Moderate or severe pancreatitis | 3-4 L in 24 h and 6-8 L in 48 h based on clinical/lab parameters |
Rate of infusion | |
Mild pancreatitis | 1.5 mL/kg/h with bolus dose 10 mL/kg/h in 1-2 h in patients with hypovolemia, BUN > 25, Hematocrit ≥ 44%, AKI, Age < 40 yr, and Alcoholic etiology |
Moderate or severe pancreatitis | 1.5-3 mL/kg/h with bolus dose 10-20 mL/kg/h in 1-2 hours or higher in hypotension |
Monitoring goals | MAP ≥ 65 mmHg, Urine output ≥ 0.5 mL/kg/h |
Hematocrit < 44% and/or BUN < 25 mg/dL at 12 and 24 h (for guided fluid rate adjustment) | |
Invasive monitoring and dynamic parameters needed in ICU patients or cardio/renal dysfunction patients | |
Duration | 24-48 h, Infusion can stop after 24 h if oral feeding can be tolerated in mild pancreatitis |
- Citation: Yaowmaneerat T, Sirinawasatien A. Update on the strategy for intravenous fluid treatment in acute pancreatitis. World J Gastrointest Pharmacol Ther 2023; 14(3): 22-32
- URL: https://www.wjgnet.com/2150-5349/full/v14/i3/22.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v14.i3.22